| IP |
Report |
Q2 2026 adjusted EBITDA — enterprise |
IN-LINE |
pred ~$536M vs. cons $535M |
MEDIUM |
| IP |
Report |
Q2 2026 Packaging Solutions North America adjusted EBITDA |
BEAT |
pred ~$390M vs. cons $386M |
MEDIUM |
| IP |
Report |
Q2 2026 Packaging Solutions EMEA adjusted EBITDA |
MISS |
pred ~$156M vs. cons $159M |
MEDIUM |
| IP |
Guide |
Adjusted EBITDA — enterprise |
LOWER |
guide ~$3.33B vs. cons $3.41B (FY2026) |
MEDIUM |
| IP |
Guide |
Free cash flow |
LOWER |
guide ~$0.40B vs. cons $0.56B (FY2026) |
MEDIUM |
| IP |
Guide |
Adjusted EBITDA ambition — enterprise |
BETTER |
guide ~$5.00B vs. cons $4.26B (FY2027) |
LOW |
| IP |
Return |
Day-1 residual (stock − beta × S&P 500) |
-4.2% |
— |
MEDIUM |
| IP |
Return |
5-day cumulative residual |
-6.5% (FOLLOW-THROUGH) |
FY2026 guide midpoint ~$3.33B vs. cons $3.41B implies negative second-half estimate revisions despite broadly in-line Q2 results; the reiterated FY2027 ambition of ~$5.00B vs. cons $4.26B is too distant and execution-dependent to prevent follow-through after the pre-earnings rally. |
MEDIUM |